Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Front Microbiol ; 13: 815136, 2022.
Article in English | MEDLINE | ID: mdl-35531287

ABSTRACT

Background: Infections may play a role in the development of systemic lupus erythematosus (SLE). Objective: To assess the link between Mycoplasma pneumonia (M. pneumonia) infection and the incidence of SLE. Method: We conducted a retrospective cohort study, which identified 116,043 hospitalized patients with M. pneumoniae between 2000 and 2012 from the Taiwan National Health Insurance Research Database and compared them with 447,839 matched inpatients who had never been diagnosed with M. pneumonia infection (at a 1:4 ratio, matched by age, gender, and index year). Their comparative risk of developing SLE was evaluated. The follow-up period was defined as the time from the initial diagnosis of M. pneumonia infection to the date of SLE diagnosis, or December 31, 2013. The incidence rates of SLE were assessed in people with and without M. pneumoniae infection. Cox proportional hazard models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs), with the uninfected group used as the reference. Results: The adjusted HR of SLE for the M. pneumoniae group was 2.97 with 95% CI = 2.18-4.05 compared with the uninfected group. The risk was most significantly higher within 0.5 years after the M. pneumoniae infection with an adjusted HR of 6.18 (95% CI = 3.82-9.97, p < 0.01). The adjusted HR for SLE from 0.5 to 2 years and from 2 to 5 years after M. pneumoniae infection was 1.59 (95% CI = 0.70-3.59, p = 0.27) and 2.42 (95% CI = 1.22-4.81, p = 0.01), respectively. Conclusion: The incidence of SLE was significantly higher in subjects infected with M. pneumoniae.

SELECTION OF CITATIONS
SEARCH DETAIL